Status:
UNKNOWN
Cystic Fibrosis and Periodontal Diseases
Lead Sponsor:
CHU de Reims
Conditions:
Cystic Fibrosis
Periodontitis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The number of CF adults is increasing year after year (61.7% in 2021) confirming that patients are living longer. These data do not leave aside the desire to see CF patients "age well" considering of ...
Detailed Description
The main objective of this study is to determine the prevalence of periodontal disease in adult CF subjects followed at CRCM of the CHU of Reims. Periodontal diseases (periodontitis and gingivitis) wi...
Eligibility Criteria
Inclusion
- inclusion criteria :
- Adult patients affected by cystic fibrosis consulting the Resource and Competence Center for Cystic Fibrosis of the C.H.U. from Reims
- Patient who signed the consent
- Patient affiliated to the French social security system
- exclusion criteria :
- A medical history that could compromise the protocol (psychiatric, medical disorders)
- Cancer
- Pregnancy
- Patients protected by law, minors, adults under guardianship and curatorship, people hospitalized without their consent and not protected by law, or people deprived of their liberty
Exclusion
Key Trial Info
Start Date :
July 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06133335
Start Date
July 20 2023
End Date
January 20 2025
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France